'The global advanced wound care market to be worth $14.6bn by 2021' says latest visiongain report

A new report by Visiongain predicts the global advanced wound care market to be worth $14.6bn by 2021. The market generated $6.2bn in 2010, according to Advanced Wound Care: World Market Prospects 2011-2021, published in November 2011.

Advanced wound care is now the physician's choice for the treatment of both acute and chronic wounds, commonly used in the treatment of burns, diabetic ulcers and pressure ulcers. The advanced wound care market has a significant opportunity to expand, owing to the increasing prevalence of diabetes and obesity leading to an increase in chronic wounds, in both developed and emerging economies. Emerging economies are beginning to transition from the traditional wound care to advanced wound care, as the products in the latter segment become more affordable and the healthcare coverage expands.

James Sheppard, healthcare industry analyst says 'The advanced wound care market has enjoyed strong growth over recent years, driven by novel devices such as negative pressure wound therapy (NPWT or VAC). Growth will be driven by biologics and novel devices. Over the course of the next decade, demand for advanced wound care will increase due to an increasing prevalence of chronic wounds as diabetes and obesity rates increase.'

Visiongain's research suggests that the advanced wound care market will benefit from the growth of emerging economies. Countries including China and India are already witnessing an increase in lifestyle related disorders such as diabetes and obesity, with increasing spending power. In the near future, mature markets such as the US and EU will drive the adoption of novel wound care devices and biologics, which command high prices in the market. Wound care biologics are still to achieve the attention they deserve, since the high cost of treatment has prevented their wide scale use. However, the market for wound care biologics will witness strong growth as their cost-effectiveness becomes evident.

Visiongain's analysis of the moist wound care, wound care devices and wound care biologics pipelines shows a number of innovative products with a great deal of promise. The current market leaders will continue to see strong growth in the early part of the decade. This new report adds to visiongain's wide range of analytical reports in healthcare and other industry areas.



For further information about this report please visit http://www.visiongain.com/Report/716/Advanced-Wound-Care-World-Market-Prospects-2011-2021

Or contact:
Sara Peerun
Sara.peerun@visiongainglobal.com
Tel: +44 020 7336 6100
www.visiongain.com

ENDS

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Telecoms, Energy, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

Visiongain Ltd
230 City Road
London
EC1V 2QY
United Kingdom

This release was published on openPR.